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Background: A major complication of a distal pancreatectomy (DP) is the formation of a post-operative
pancreatic fistula (POPF). In spite of the utilization of numerous surgical techniques no consensus on an
appropriate technique for closure of the pancreatic remnant after DP has been established yet. The aim
of this study was to analyse the impact of pancreatoenteral anastomosis (PE) vs. direct closure (DC) of the
pancreatic remnant on POPF.
Methods: A total of 198 consecutive patients who underwent a distal pancreatectomy between 2002
and 2010 at our institution were retrospectively analysed for post-operative morbidity and mortality.
Results: One hundred and fifty-one patients (76.3%) received DC whereas PE was performed in 47
patients (23.7%). The incidence of POPF was higher in the DC group (22% vs. 11%), whereas the rate of
post-operative haemorrhage was higher in the PE group (11% vs. 7%). However, these differences were
not significant. Additionally, there were no significant differences in overall post-operative morbidity and
mortality between the groups.
Conclusions: The performance of PE instead of DC may be considered as a safe alternative in individual
patients, but it does not significantly lead to a general improvement in post-operative outcome after DP.
An interdisciplinary collaboration in the prevention and treatment of POPF therefore remains essential.
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Introduction
A distal pancreatectomy (DP) was first performed by Billroth in
1884 and is defined as the resection of pancreatic parenchyma to
the left side of the superior mesenteric vein.1 Current indications
for DP include malignant and benign lesions of the pancreas
corpus and tail as well as chronic pancreatitis and trauma.2,3 Distal
carcinomas typically show a late onset of clinical symptoms and
therefore are often large and unresectable at presentation.4,5 Hence
DP is performed less frequently than resections of the pancreas
head region. Recent advances in operative technique and peri-
operative management have reduced the mortality rate, which is
reported to be less than 3% after pancreatic resections.6,7 However,
operation-associated morbidity after DP still remains high and
ranges from 10% to 40% as well in high volume centres.6,8
Post-operative pancreatic fistula formation (POPF) as the
most common and clinically relevant complication is associated
with local and general problems such as the formation of
intra-abdominal abscesses, delayed gastric emptying, post-
pancreatectomy haemorrhage and sepsis.7 Patient age, duct
obstruction, trauma and the texture of the pancreas tissue have
been identified as potential risk factors for POPF.9 Additionally,
surgical techniques are considered as a major risk factor, and
therefore, numerous modifications have been described in an
attempt to optimize the procedure on the pancreatic remnant.
These techniques include hand-sewn sutures or stapled closure
(or a combination of both), ultrasonic dissection, pancreatoen-
teral anastomosis, application of meshes and sealing by use of
fibrin glue.10–15 The two most established techniques, hand-sewn
sutures and stapled closure, were recently compared in a random-
ized, controlled, multicentre study.16 No benefit of performing
stapled closure instead of hand-sewn sutures could be
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demonstrated, and a total POPF incidence of 30% was found.16
Other studies have reported particularly divergent results regard-
ing the closure technique, with an incidence of POPF between
32% and 60%.17,18 Another technique, the performance of a PE as
pancreatojejunostomy (PJ) or pancreatogastrostomy (PG), has
become more common recently, especially in patients with an
underlying ‘hard’ tissue remnant as in chronic pancreatitis.
However, this technique has only been investigated in small
sample studies, and no benefit could be demonstrated in compari-
son to direct closure (DC).12–14 The aim of this present study was
to compare the significance of a PE vs. DC of the pancreatic stump
at a high-volume tertiary care centre, with the main focus on
post-operative morbidity and mortality.
Patients and methods
Study design
A retrospective analysis of 198 consecutive patients who under-
went a distal pancreatectomy between 1st February 2002 and 1st
June 2010, at the Department of General, Visceral and Transplan-
tation Surgery at Charité University Hospitals, Berlin, Campus
Virchow was performed. In this study, surgeons were trained and
experienced in both performing DC (hand-sewn sutures or
stapled closure) or PE (PJ or PJ), and the decision on the type of
proceeding with the pancreatic remnant was individually deter-
mined. Medical records from a prospective database of pancreatic
resections were reviewed, and data were documented in a
Windows Excel table format. The patients were then divided into
two groups depending on the type of procedure performed for the
pancreatic remnant (DC vs. PE). The type of DC (hand sutures vs.
stapling) and the location of the PE (pancreatojejunostomy vs.
pancreatogastrostomy) were documented, and patient data were
reviewed for selected pre-operative and operative data as well as
for postoperative morbidity and mortality.
Surgical technique
A distal pancreatectomy was always performed as open surgery. At
laparotomy, hepatic or peritoneal metastases were initially
excluded by complete exploration of the stomach. A decision on
whether to perform an additional splenectomy was performed by
the surgeon taking the underlying disease into account. Access to
the omental bursa was established by splitting of the gastrocolic
ligament from the left to the right side and preparing the vasa
gastroepiploica. After retraction of the stomach and inspection of
the pancreas surface were performed, local resectability of the
lesion and the extent of the resection (i.e. the need for additional
organ resection) were determined based on local findings such as
vascular and/or other organ infiltration. If the lesion was resect-
able, the lower margin of the pancreas was prepared by incision of
the retroperitoneum to mobilize, and, if possible, tunnel under,
the pancreas. In cases of underlying malignant disease, a standard
lymphadenectomy was performed. After preparation of the portal
vein, a wooden flute was inserted into the space anterior to the
veins and posterior to the corpus of the pancreas. If a splenectomy
was performed as a next step, the splenic artery was sewn over
close to the outflow of the celiac trunk using 4-0 Prolene sutures
and was peripherally ligated. The pancreas was then cut through
the left of the superior mesenteric vein using electrocautery. After
separation of the left side of the pancreas from the retroperito-
neum under careful preservation of the left adrenal gland and
ligation of the lienal vein at the junction of the portal vein, the
pancreas and spleen were then removed from the situs. Subse-
quent closure of the main pancreatic duct of the pancreatic
remnant was achieved by a stitch ligation using 4-0 Prolene
sutures. A DC of the pancreas remnant was either performed
using hand sutures with 4-0 Prolene sutures placed in the form of
‘U’ shapes or using a linear stapling device (Ethicon TL 60 1.0–
2.5 mm, Johnson & Johnson Medical GmbH, Norderstedt,
Germany) armed with a 60-mm magazine. In case of a pancrea-
toenteral anastomosis, either a pancreatojejunostomy or a pancre-
atogastrostomy was performed using mattress sutures placed in a
‘U’ shape combined with two corner sutures. Every patient
received at least one intra-abdominal drain (Degania Silicone
Europe GmbH, Regensburg, Germany) to measure post-operative
lipase/amylase levels and drain output. Pancreatic tissue texture
was assessed intra-operatively by the operating surgeon and was
considered as either ‘soft’ or ‘hard’.
Standard post-operative care
All patients were monitored for at least one day at our surgical
intensive care unit. Amylase and/or lipase levels were monitored
daily in the serum and in the intra-operatively placed abdominal
drains on the first and fourth post-operative day. Routine peri-
operative antibiotics [Cefuroxime 1 g intravenously (i.v.) and
Metronidazole 500 mg i.v.] were given. Subcutaneous somatosta-
tin therapy (100 mg) was routinely administered three times daily
in the post-operative course. In the absence of signs of a pancre-
atic fistula, oral food intake was begun depending on the clinical
presentation and tolerance.
The diagnosis of a POPF was based on the definition of the
International Study Group on Pancreatic Fistula (ISGPF).19
According to the ISGPF definitions Grades A, B, and C fistulae
were considered as POPF. However, the levels of amylase in the
intra-operatively placed drains were not available for all subjects
in our database. The lipase levels in the drains were always mea-
sured. We therefore slightly modified the ISGPF definitions and
used amylase or lipase levels in the drains to define the existence of
a POPF.
Post-pancreatectomy haemorrhage (PPH) was also defined
based on the ISGPF definitions.20 In addition to the clinical
presentation, the diagnosis of a dehiscence of the pancreatoenteric
anastomosis was based on radiological and/or operative
confirmation.
Statistical analysis
For the statistical analysis, PASW Statistics 19 (SPSS Software,
IBM Company, Chicago, IL, USA) was used. For continuous vari-
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ables, the median was reported with the range. Analysis of
specific-risk factors was performed using t-tests or the Mann-
Whitney U-test. Categorical variables were described using fre-
quencies and percentages. For categorical variables, chi-square
tests were used. A P-value <0.05 was defined as significant.
Results
Patient baseline data
Between 1st February 2002 and 1st June 2010, a total of 198
consecutive distal pancreatectomies were performed at the
Department of General, Visceral and Transplantation Surgery at
Charité University Hospitals, Berlin, Campus Virchow. Of these,
in 151 patients (76%), a DC of the pancreas remnant was per-
formed, whereas in 47 patients (24%), a PE was performed. There
were 108 males (55%) and 90 females (45%), with a median age of
61 years (range, 17–88). The indication for distal pancreatectomy
was pancreatic adenocarcinoma in 114 patients (58%), chronic
pancreatitis in 16 patients (8%), pancreas pseudocyst in 12
patients (6%), metastasis to the pancreas in 7 patients (4%),
gastric carcinoma in 16 patients (8%), neuroendocrine tumour in
16 patients (8%) and other indications (ganglioneuroma, gas-
trointestinal stromal tumour, kidney carcinoma, duodenal carci-
noma and liposarcoma) in 17 patients (9%). Patients with chronic
pancreatitis underwent operations for intractable pain. As an
additional surgical procedure, a splenectomy was performed in
173 patients (84%), liver resection in 15 patients (8%), partial or
total gastrectomy in 45 patients (23%) and oesophageal resection
in 4 patients (2%) (Table 1).
Direct closure of the pancreas remnant vs.
pancreatoenteral anastomosis
The median operation time was 230 min when performing a DC
of the pancreas remnant using either hand sutures or a stapling
device vs. 227 min when performing a PE either as PG or PJ. In the
DC group pancreas tissue texture was found to be ‘soft’ in 103
patients (68%), ‘hard’ in 32 patients (21%) and not assessed in 16
patients (11%). In the PE group, pancreas tissue texture was docu-
mented as ‘soft’ in 20 patients (43%), ‘hard’ in 21 patients (45%)
and not assessed in 6 patients (13%). The incidence of major
post-operative morbidity after DC of the pancreas remnant was
26% (39/151) in comparison to 19% (9/47) after performing a
pancreatoenteral anastomosis. A POPF occurred in 22% (33/151:
Grade A 7%, Grade B 7% and Grade C 7%) of the patients after
DC vs. 11% (5/47: Grade A 4%, Grade B 4%, Grade C 2%) of the
patients after pancreatoenteral anastomosis. The incidence of
POPF in patients with an underlying ‘soft’ pancreas tissue
remnant was 23% (24/103) in the DC group vs. 14% (3/21) in the
PE group. In patients with an underlying ‘hard’ pancreas tissue the
incidence of POPF was 16% (5/32) in the DC group and 10% in
the PE (2/20) group.
The incidence of PPH was 7% (11/151) in the DC group vs.
11% (5/47) in the PE group. The median length of hospital stay
was 20 days in the DC group vs. 19 days in the PE group.However,
these differences were not significant. The overall mortality was
4% after DC (6/151) and 2% after PE (1/47). Four patients died as
a result of PPH: two patients died because of septic multi-organ-
failure and one patient died because of acute cardiac failure. There
were no significant differences regarding operative factors or post-
operative morbidity and mortality between the two groups
(Table 2).
Direct closure of the pancreas remnant: hand sutures
vs. stapler device
Hand sutures were used as the closing technique of the pancreas
remnant in 136 patients (90%), whereas a stapler device was used
for closure in 15 patients (10%). The median operation time
was 235 min when performing hand sutures in comparison to
193 min when using a stapler device for pancreatic remnant
closure. Major morbidity occurred in 25% (34/136) and POPF in
21% (28/136) of the patients after hand sutures in contrast to an
incidence of major morbidity of 40% (6/15) and POPF of 33%
(5/15) after stapler device closure. However, these differences were
not significant. Additionally, there were no significant differences
between the groups in the rates of re-operation (14% vs. 20%), the
median length of hospital stay (19 days vs. 28 days) and overall
mortality (4% vs. 0%). The incidence of PPHs was significantly
Table 1 Characteristics of the patients
Direct closure
of pancreas
remnant (DC)
Pancreatoenteral
anastomosis (PE)
Number of patients 151 47
Median age (range) 62 (17–88) 57 (26–87)
Gender (male) 84 (56%) 24 (51%)
Indication
Pancreatic carcinoma 95 (63%) 19 (40%)
Chronic pancreatitis 8 (5%) 8 (17%)
Pancreas pseudocyst 7 (5%) 5 (11%)
Metastasis 2 (1%) 5 (11%)
Gastric carcinoma 16 (11%) 0
Neuroendocrine tumour 11 (7%) 5 (11%)
Others 12 (8%) 5 (11%)
Median operation time 230 min 227 min
Additional organ resection
Splenectomy 129 (85%) 45 (96%)
Partial/total gastrectomy 39 (26%) 6 (13%)
Liver resection 13 (9%) 3 (6%)
Oesophagal resection 4 (3%) 0
Pancreas tissue texture
Soft 103 (68%) 21 (45%)
Hard 32 (21%) 20 (43%)
Not assessed 16 (11%) 6 (13%)
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higher (P = 0.05) when performing a stapler closure (3/15 or 20%)
in comparison to hand suture closure of the pancreatic remnant
(8/136 or 6%) (Table 3).
Pancreatoenteral anastomosis: pancreatojejunostomy
vs. pancreatogastrostomy
A pancreatojejunostomy was performed for PE in 38 patients
(81%). Nine patients (19%) received a pancreatogastrostomy.
There were no significant differences in the median operation
time (231 min vs. 213 min), the incidence of post-operative mor-
bidity (16% vs. 33%), the formation of POPF (11% vs. 11%) or
PPH (8% vs. 22%). There were also no significant differences in
the rate of relaparotomy (16% vs. 11%) or the median hospital
stay (20 days vs. 17 days). However, the overall mortality was
significantly increased (P = 0.04) when a PG was performed (1/9
or 11%) than when a PJ was performed (0/38) (Table 4).
Risk factors for POPF
According to the ISGPF definitions, POPF Grade A occurred in 13
patients (7%), Grade B in 13 patients (7%) and Grade C in 12
patients (6%). Thus, the total incidence of POPF was 19% (38/
198). Individual risk factors identified for POPF were patient’s age
greater than 65 years, operation time greater than 300 min and an
additional organ resection. The performance of a DC or PE did
not show a significant impact on POPF.
Discussion
The clinical outcome in pancreatic surgery has improved consid-
erably in the last decades with a consistent reduction of post-
operative morbidity and mortality.21 However, with a reported
incidence of 10% to 40%, POPF remains the most common and
clinically relevant complication after DP.6,8 POPF is associated
with complications such as pancreatic fluid collection, intra-
abdominal abscesses, wound infection and sepsis, and therefore
also has a significant effect on health care costs and resources.22
Pratt et al. emphasized the economic burden of POPF and dem-
onstrated that costs increased in tandem with the severity Grade
of POPF.23 Poor nutritional status (defined as low albumin and/or
recent weight loss), advanced patient age, male gender, higher
bodymass index, duct obstruction and ‘soft’ pancreatic tissue have
been identified as risk factors for POPF.7,9,24 In addition, various
technical factors including the method of stump closure, con-
comitant organ resection (i.e. splenectomy), transfusion of eryth-
rocyte concentrates and a longer operation time were shown to
correlate with an increased risk for POPF.7,8 Surgically, the proce-
dure performed on the pancreatic stump remains the ‘Achilles
heel’ of DP, and therefore, numerous modifications of the opera-
tive technique for reducing the occurrence of POPF have been
undertaken, although a gold standard has not been established
yet. A systematic review by Knaebel et al. revealed that the hand-
sewn closure and stapler closure were the two most common
techniques for DP.18 Kleef et al. observed a significantly increased
risk of POPF with stapled closure, whereas other investigators
have reported increased POPF rates with sutured closure of the
pancreatic remnant.7,11,25 To further complicate matters, other
studies have shown no differences between the twomethods in the
post-operative outcome.9,10,26
In this study, the majority of DCs were performed using hand
sutures in 136 patients (90%) in comparison to stapler closure in
15 patients (10%). Hand-sewn sutures carry the risk of tearing,
especially of the duct sutures, whereas in the case of stapling, if
pancreatic sutures are torn out or the tissue tears, small parts of
the pancreatic cutting surface are not sealed, and POPF can occur.
Additionally, Eguschi et al. speculated that ‘hard’ pancreatic tissue
is more likely to be crushed when compressed by a stapler.27
Table 2 Post-operative patient factors and morbidity
Closure of
pancreas
remnant
Pancreatoenteral
anastomosis
P-value
(n = 151) (n = 47)
Median operation
time (SD)
230 (86)min 227 (71)min NS
Major morbidity 39 (26%) 9 (19%) NS
POPF 33 (22%) 5 (11%) NS
POPF Grade A 11 (7%) 2 (4%) NS
POPF Grade B 11 (7%) 2 (4%) NS
POPF Grade C 11 (7%) 1 (2%) NS
PPH 11 (7%) 5 (11%) NS
Re-operation 21 (14%) 7 (15%) NS
Median hospital
stay
20 days 20 days NS
Mortality 6 (4%) 1 (2%) NS
NS, non-significant (significant if <0.05).
Table 3 Closure of the pancreas remnant: hand sutures vs. stapler
Hand suture Stapler P-value
(n = 136) (n = 15)
Median operation
time (SD)
235 ( 88) min 193 (53) min NS
Major morbidity 34 (25%) 6 (40%) NS
POPF 28 (21%) 5 (33%) NS
POPF Grade A 10 (7%) 1 (7%) NS
POPF Grade B 9 (7%) 2 (13%) NS
POPF Grade C 9 (7%) 2 (13%) NS
PPH 8 (6%) 3 (20%) 0.05
Re-operation 19 (14%) 3 (20%) NS
Median hospital
stay
19 days 28 days NS
Mortality 6 (4%) 0 NS
NS, non-significant (significant if <0.05); POPF, post-operative pancreatic
fistula formation.
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Thus, at this institution hand sutures are considered the stan-
dard procedure for DC. Stapler closure was performed in the
context of the DISPACT study, a recent randomized, controlled,
multicentre study..16 The results of our study demonstrated no
differences between hand and staple sutures for closure of the
pancreatic remnant with respect to operation time, the incidence
of POPF or post-operative morbidity and thereby reflect the
results of the DISPACT study.
In patients with an underlying ‘hard’ pancreas tissue, the per-
formance of a PE may be a safe option. Additionally, if there is a
duct obstruction in the pancreatic head or periampullary region,
then the risk of POPFmay be reduced when performing a PE. The
performance of a PE is limited by the extent of the pancreatic
resection because a marginally sized remnant from the right side
of the pancreas can only be mobilized enough to perform a PE. In
our study, a PE was performed in 20 patients (43%) with an
underlying ‘hard’ pancreas tissue remnant and in 21 patients
(45%) with tumours located in the distal pancreatic tail. The type
of PE, PJ vs. PG, needs to be evaluated individually. PG allows
good endoscopic accessibility of the anastomosis region.However,
during DP PG is often limited by the difficult mobilization of the
pancreatic head and body remnant and PJ is therefore often more
safe and simple to perform. In this study, nine patients (19%)
received PG. PJ was performed in 38 patients (81%). No signifi-
cant differences in postoperative outcome could be demonstrated.
As a conclusion of this study a benefit of performing a PE,
whether performed as PJ or PG, instead of a DC of the pancreatic
remnant, whether with hand-sewn sutures or a stapler device,
could not be demonstrated with regard to operative or post-
operative outcome. Other small cohort studies have also failed to
confirm a reduced incidence of POPF for PE during a distal pan-
createctomy.12,14 Owing to the small sample sizes, the non-
randomized study designs and inconsistent definitions for POPF,
the impact of PE remains hard to interpret. Other authors have
also suggested that POPF after a PE could result in potentially
more hazardous complications (such as activation of pancreatic
enzymes and bacterial contamination) than POPF after a DC.7 As
an interdisciplinary approach to reduce the incidence of POPF
after DP, Abe et al. suggested pre-operative endoscopic pancreatic
stenting to prevent pancreatic leakage.28 They reported no POPF
but found a 20% incidence of mild to acute pancreatitis after stent
placement. As a result of this risk of pre-operative pancreatitis
and, therefore, a potential delay in the beginning of surgical treat-
ment options, especially in oncological patients, we do not include
pre-operative stenting as a standard procedure at this institution.
Oida et al. described a potential alternative to pre-operative stent-
ing by inserting transduodenal pancreatic juice drainage during
DP in 10 patients and reported no POPF.29 However, their study
was limited by the small sample size. Post-operative pancreatic
stenting showed good results in the treatment of POPF but has not
been established yet as a routinely prophylactic procedure to
reduce the POPF rate after DP.30
The results of this study also emphasize that additional organ
resection, such as a splenectomy or oesophageal, stomach or liver
resection, is associated with an increased rate of POPF as well as
post-operative morbidity, in general, after DP. Extended surgery
results in more blood loss, longer hospital stay and increased
mortality. Additionally, extension of the surgery can lead to com-
promised healing of the pancreatic remnant as a result of a
reduced blood supply of the cut surface; this explains the
increased risk for POPF.31 Nevertheless, in the presence of an
oncological indication for DP, we are often left with no other
choice but additional organ resection (i.e. splenectomy, gastrec-
tomy or partial liver resection) in an attempt to optimize the
oncological outcome. However, the indication for a splenectomy
should be carefully evaluated in underlying benign diseases.
As in other fields of surgery, laparoscopic techniques have also
been reported for DP, and laparoscopic DP (LDP) is now consid-
ered a safe and effective treatment for benign and borderline
malignant tumours of the pancreas.32 In a recent study, Mehta
et al. reported a significant reduction in blood loss and hospital
stay after performing a LDP in comparison to an open DP and
Table 4 Pancreatoenteral anastomosis: pancreatogastrostomy vs. pancreatojejunostomy
Pancreatojejunostomy Pancreatogastrostomy P-value
(n = 38) (n = 9)
Median operation time (SD) 231 ( 72)min 213 ( 68)min NS
Major morbidity 6 (16%) 3 (33%) NS
POPF 4 (11%) 1 (11%) NS
POPF Grade A 1 (3%) 1 (11%) NS
POPF Grade B 2 (5%) 0 NS
POPF Grade C 1 (3%) 0 NS
PPH 3 (8%) 2 (22%) NS
Re-operation 6 (16%) 1 (11%) NS
Median hospital stay 20 days 17 days NS
Mortality 0 1 (11%) 0.04
NS, non-significant (significant if <0.05); POPF, post-operative pancreatic fistula formation.
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showed no differences in overall morbidity and POPF.33 However,
not all surgeons are qualified for LDP. Furthermore, left-sided
pancreas cancers often present in a locally advanced stage by the
time of diagnosis, and therefore LDP does not always allow a
sufficient regional dissection to perform an oncological effectual
resection.
The statistical power of this study is surely limited by the small
sample size of patients. Furthermore, the retrospective study
design may have lead to a selection bias in how patients were
chosen for PE. However, the results of our study demonstrate that
both,DC and PE,may safely be performed. POPF remains a major
problem after DP although with a major impact on the postop-
erative course and postoperative outcome in general. The ideal
type of procedure with the pancreatic stump, DC vs. PE, can only
be individually evaluated and may therefore contribute to some
reduction in POPF rate. In spite of further attempts to optimize
the surgical technique, emphasis also needs to be placed on amore
interdisciplinary approach in pre-operative prevention and post-
operative management of POPF.
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